Which BEERS category is linked to stroke or death risk in dementia patients?

Which BEERS category is linked to stroke or death risk in dementia patients?

• A. Anticholinergic drugs
• B. Antipsychotics
• C. Benzodiazepines
• D. Diabetes medications

Answer: (B)

Antipsychotics are flagged in the BEERS criteria for dementia patients because they are associated with a higher risk of stroke and death. In elderly individuals with dementia, these medications have shown increased mortality in studies and warnings from the FDA, particularly when used to manage agitation, aggression, or psychosis. The risk appears relatively soon after starting treatment and can be influenced by dose and duration, so these drugs are generally reserved for severe behavioral symptoms when nonpharmacologic approaches have failed, and then used at the lowest effective dose for the shortest possible time with close monitoring. While anticholinergic drugs and benzodiazepines carry other important risks for older adults—delirium, falls, and cognitive worsening—the specific BEERS-category concern for dementia patients that links directly to stroke or death is the antipsychotics category. Diabetes medications aren’t the category primarily associated with stroke or death risk in this context.

Antipsychotics are flagged in the BEERS criteria for dementia patients because they are associated with a higher risk of stroke and death. In elderly individuals with dementia, these medications have shown increased mortality in studies and warnings from the FDA, particularly when used to manage agitation, aggression, or psychosis. The risk appears relatively soon after starting treatment and can be influenced by dose and duration, so these drugs are generally reserved for severe behavioral symptoms when nonpharmacologic approaches have failed, and then used at the lowest effective dose for the shortest possible time with close monitoring. While anticholinergic drugs and benzodiazepines carry other important risks for older adults—delirium, falls, and cognitive worsening—the specific BEERS-category concern for dementia patients that links directly to stroke or death is the antipsychotics category. Diabetes medications aren’t the category primarily associated with stroke or death risk in this context.